Classical cadherin adhesion receptors play critical roles in tissue organization. They mediate cell-cell recognition and morphogenesis during development and support cohesion in established tissues. Cadherin dysfunction can have detrimental effects such as promoting the metastasis of epithelial cancers. The diverse morphogenetic roles of cadherin receptors are not due solely to their intrinsic adhesive properties but also depend on the crosstalk between cadherins and key elements of the cytoplasmic machinery involved in signal transduction, membrane trafficking, and cytoskeletal organization. Although cadherins have long been thought to cooperate with the actin cytoskeleton, less attention has been paid to their capacity to interact with microtubules. Reporting in this issue, Meng et al. (2008) now identify a new cadherin-based protein complex in mammalian epithelial cells that can anchor microtubule minus ends to the zonula adherens (ZA) and is necessary for the biogenesis of this specialized junction.
Cadherins localize at epithelial cell-cell contacts in two patterns: the first comprises clusters and strands distributed throughout the lateral interface, and the second consists of an apically located linear band that is thought to mark the ZA, a specialized cell-cell junction (Kametani and Takeichi, 2007) . As little is known about how the ZA is generated and maintained, Meng and colleagues set out to identify new regulators of the ZA in mammalian cells by searching for proteins that bind to the cadherinassociated protein p120-catenin. They uncover a new interacting partner, a pleckstrin homology (PH) domain protein of unknown function called PLEKHA7 (PH domain-containing family A, member 7). Immunoprecipitation analysis reveals that PLEKHA7 interacts with the E-cadherin-catenin complex. PLEKHA7 specifically colocalizes with the pool of E-cadherin at the ZA in a p120-dependent manner. When p120 was depleted from the cells, or when binding of E-cadherin to p120 was disrupted by mutation, PLEKHA7 was no longer found at the cell junctions. Importantly, Meng et al. report that PLEKHA7 expression is needed for the maintenance of ZA integrity. Specifically, PLEKHA7 appears to promote the incorporation of cadherin clusters into the higher-order structure of the ZA. The authors further identify another poorly characterized protein, which they call Nezha (formerly KIAA1543), as a binding partner of PLEKHA7. Depletion of Nezha from cultured human cells disrupted the ZA, implying that Nezha might mediate the impact of PLEKHA7 on the biogenesis of the ZA. Indeed, localization of Nezha to the ZA is perturbed when PLEKHA7 is absent. Interestingly, Nezha is only found at the ZA at late stages of junction maturation, after PLEKHA7 is already in place. Although PLEKHA7 appears to be necessary to recruit Nezha into the ZA, the association between these two proteins is likely to be highly regulated.
During their characterization of Nezha, the authors make the surprising observation that it is a microtubule minusend-binding protein. Microtubules are polarized polymers whose ends possess distinct dynamic properties. Microtubule plus ends serve as sites of polymerization; they are highly dynamic and associate with a large number of cellular factors (Akhmanova and Steinmetz, 2008) . The minus ends, on the other hand, serve as sites of microtubule anchoring or disassembly, and only a few proteins are known to specifically interact with them (Dammerman et al., 2003) . The authors find that endogenous Nezha localizes to the minus ends of noncentrosomal microtubules in vivo and confirm that this protein binds to the minus ends of microtubules in vitro. Time-lapse microscopy of live cultured human cells reveals that Nezha-containing foci at cell-cell contacts appear to serve as sites of microtubule outgrowth and anchoring. Further, depolymerization of microtubules with nocodazole ultimately causes the ZA to fragment. This suggests an attractive model whereby the cadherin-based Nezha/PLEKHA7 complex supports ZA biogenesis by anchoring microtubules at their minus ends (Figure 1 ). Obtaining definitive proof for this model will require evidence that a significant population of microtubules is anchored by their minus ends at the ZA, which remains a challenge due to the high density of threedimensional microtubule networks in differentiated epithelial cells.
How might a minus-end-anchoring apparatus contribute to the biogenesis of the ZA? An important property of microtubule polarity is to provide directional tracks for motor-dependent transport of macromolecules and membranes. Indeed, the contribution of microtubules to cell-cell junctions has often been framed in terms of membrane transport. Consistent with this, Meng et al. report that kinesin-14/KIFC3, the minus-enddirected motor previously implicated in apical membrane transport in epithelial cells (Noda et al., 2001) , is required for ZA integrity. It is tempting to speculate that Nezha-mediated anchorage of microtubule minus ends orients tracks for KIFC3-based delivery of molecules necessary for the biogenesis and maintenance of the ZA. However, the exact nature of the potential cargo remains to be determined. Interestingly, KIFC3 itself localizes to the ZA in a Nezha-and PLEKHA7-dependent fashion, suggesting that it may play a structural or signaling role or even participate in microtubule organization at epithelial cell-cell junctions.
Irrespective of the underlying mechanism, characterization of Nezha and PLEKHA7 function emphasizes the importance of protein cooperativity in ZA biogenesis. Although PLEKHA7 is necessary to recruit Nezha into junctions, depletion of Nezha also causes PLEKHA7 to be lost from junctions. Thus, the incorporation of Nezha appears to stabilize PLEKHA7, either directly or indirectly. Similarly, microtubule depolymerization leads to the eventual loss of KIFC3 and Nezha and disruption of the ZA itself. This implies that the ZA, rather than being a static structure, is dynamic. Such cooperativity is likely to extend to other signaling and cytoskeletal interactions at the ZA.
The findings of Meng et al. add to a growing body of evidence linking cadherins and microtubules. Microtubule disruption by overall depolymerization or by freezing the dynamic activity of the plus ends can perturb cadherinbased cell-cell contacts (Stehbens et al., 2006; Waterman-Storer et al., 2000) . Furthermore, other studies provide evidence that the dynamic plus ends of microtubules can also extend into cadherin-based junctions. Microtubules in fibroblasts and isolated epithelial cells are often organized as arrays with their minus ends anchored at centrosomes and plus ends facing the cell periphery. However, relocation of microtubule minus ends from the centrosomes to either the apical surface or to cell-cell contacts often occurs during epithelial biogenesis and is a process that depends on the microtubule minus-end-anchoring factor ninein (Dammerman et al., 2003; Lechler and Fuchs, 2007) . Interestingly, Meng and colleagues report that Nezha does not colocalize with ninein, and, unlike PLEKHA7 and ninein, it does not bind to centrosomes. This observation will require further investigation to elucidate its place in the regulation of microtubule minus ends. p120-catenin recruits Nezha and PLEKHA7 to the E-cadherin/β-catenin complex at the zonula adherens (ZA). Nezha binds to microtubules at their minus ends and, together with the microtubule minus-enddirected motor KIFC3, supports the organization of cadherin clusters into the ZA.
Most importantly, this new study sheds light on the enigmatic biology of the ZA. This distinctive structure, first characterized by electron microscopy (Farquhar and Palade, 1963) , is thought to be a higher-order molecular apparatus built on a cadherin core that also includes many other membrane proteins such as noncadherin adhesion molecules (Gumbiner, 2005) . The observation by Meng et al. that Nezha, PLEKHA7, and KIFC3 appear to promote the accumulation of cadherin in the ZA at the expense of the cadherin pool at the cell's lateral contacts further supports the notion that the ZA represents a higher-order organization of cadherins at cell-cell junctions. Many functions have been suggested for the ZA beyond basic cadherin adhesion, including cell signaling, apical cell morphogenesis, and adhesive stabilization. However, efforts to dissect these roles for the ZA have been hampered by a lack of strategies to specifically perturb ZA formation without affecting basic cadherin function. The identification of mechanisms that regulate epithelial cell junction organization by Meng et al. and others opens the way for future studies examining the specific cellular and tissue functions of the ZA.
Because of heightened genomic instability, cancer cells often have a complex karyotype with many gains and losses in gene copy number. Although comparative genome hybridization (CGH) technologies now enable the mapping of copy number gain or loss at high resolution, the genomic regions pinpointed in such studies are still quite large and may contain tens or even hundreds of genes. A key question that often remains to be answered is which of the many genes in these regions are the "drivers" of the oncogenic phenotype and which are "passengers" whose altered expression does not contribute to the genesis of the cancer. In an elegant study in this issue, Zender et al. (2008) describe an integrative genomics approach to identify the true drivers of oncogenicity in regions of copy number loss in hepatocellular carcinoma, leading to the identification of new tumor suppressor genes.
Zender et al. began by generating high-resolution array CGH maps for 98 human hepatocellular carcinomas (Figure 1) . They concentrated on small (<5 MB) recurrent deletions because such focal deletions are most likely to contain tumor suppressor genes. In total, 58 recurrent deletions were identified, together harboring 362 candidate tumor suppressor genes. To ask which of these genes are relevant to liver carcinogenesis, the authors turned to a previously established mouse model for this disease, consisting of murine embryonic hepatocytes immortalized by loss of the tumor suppressor p53 and expression of the c-Myc oncogene (two events that frequently occur in human hepatocellular carcinoma). Although these hepatocytes are immortal, they do not form tumors in mice and can only be induced to become tumorigenic by introduction of additional oncogenes or tumor suppressor genes (Xue et al., 2008; Zender et al., 2005 Zender et al., , 2006 . To ask which of the 362 candidate human tumor suppressor genes drive the oncogenic process, the authors first identified mouse orthologs for 301 of these genes and obtained retroviral vectors to deliver short hairpin RNAs (shRNAs) to knock down these genes. In a pilot experiment, the authors tested "positive control" shRNAs corresponding to two components of the
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